| 1 |
30791790 | Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review. | 2018 Dec |
2 |
| 2 |
26595724 | Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. | 2016 Jan |
2 |
| 3 |
27276081 | Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data. | 2016 |
1 |
| 4 |
25775312 | Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. | 2015 Mar 17 |
1 |
| 5 |
25820703 | The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. | 2015 May 5 |
3 |
| 6 |
25847572 | Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients. | 2015 Nov |
1 |